Destiny Pharma Plc operates as a clinical biotechnology company, which engages in the discovery, development and commercialization of new antimicrobial products. Its products include XF drug series, XF-73 and Pipeline. The company was founded by Suzanne Brewer, Kevin Brewer and William Guy Love on March 4, 1996 and is headquartered in Brighton, the United Kingdom.
Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!